Verastem, Inc. (VSTM)
4.27
+0.14
(+3.39%)
USD |
NASDAQ |
May 21, 16:00
4.25
-0.02
(-0.47%)
After-Hours: 19:59
Verastem Research and Development Expense (TTM) : 123.67M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Altimmune, Inc. | 66.69M |
| Ocugen, Inc. | 39.60M |
| BioXcel Therapeutics, Inc. | 27.94M |
| Xilio Therapeutics, Inc. | 67.60M |
| ACADIA Pharmaceuticals, Inc. | 327.40M |